TABLE 1.
Predicted structural effects | Mutations | Numbers of mutations | N a | Age of onset(years) | Variable | P |
---|---|---|---|---|---|---|
substantial effect | eIF2Bε[Arg195His] | 1–2 | 13 | 0.8(0.3–34) | 13.08 | <0.001 |
2 | 6 | 0.7(0.3–0.9) | Ha = 3.63 | <0.001 | ||
Hb = 0.09 | >0.05 | |||||
1 | 7 | 4.5(0.3–34.0) | Hc = 0.41 | >0.05 | ||
0 | 290 | 3.6(0–62.0) | ||||
substantial effect | eIF2Bε[Arg269Gln] | 1–2 | 9 | 1.2(0.7–4.5) | 2.77 | <0.01 |
2 | 2 | (1.2–1.6) | ||||
1 | 7 | 1.1(0.7–4.5) | Hd = 2.34 | <0.05 | ||
0 | 294 | 3.7(0–62.0) | ||||
small effect | eIF2Bβ[Glu213Gly] | 1–2 | 22 | 5.5(1.5–17.0) | 1.84 | >0.05 |
2 | 17 | 5.0(1.5–17.0) | ||||
1 | 5 | 7.0(1.7–17.0) | ||||
0 | 281 | 3.5(0–62.0) | ||||
small effect | eIF2Bβ[Gly200Val] | 1 | 7 | 1.7(0.3–22.0) | 0.94 | >0.05 |
0 | 296 | 3.6(0–62.0) | ||||
small effect | eIF2Bε[Thr91Ala] | 1–2 | 5 | 2.0(1.5–3.0) | 0.11 | >0.05 |
0 | 298 | 3.6(0–62.0) | ||||
small effect | eIF2Bγ[Ala87Val] | 1–2 | 10 | 29.0(2.1–61.0) | 2.68 | <0.01 |
2 | 6 | 26.5(2.1–61.0) | ||||
1 | 4 | 38.5(2.3–57.0) | ||||
0 | 293 | 3.5(0–62.0) |
N: number of patients with 0, 1 or 2 missense mutations; H a : people carried two eIF2Bε[Arg195His] compared with those without eIF2Bε[Arg195His] mutation; H b : people carried two eIF2Bε[Arg195His] compared with those carried one eIF2Bε[Arg195His] mutation; H c : people carried one eIF2Bε[Arg195His] compared with those without eIF2Bε[Arg195His] mutation. H d : people carried one eIF2Bε[Arg269Gln] compared with those without eIF2Bε[Arg269Gln] mutation.